These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 19800102)
1. N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin. Song Y; Oda Y; Hori M; Kuroiwa K; Ono M; Hosoi F; Basaki Y; Tokunaga S; Kuwano M; Naito S; Tsuneyoshi M Hum Pathol; 2010 Feb; 41(2):214-22. PubMed ID: 19800102 [TBL] [Abstract][Full Text] [Related]
2. N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma. Akiba J; Ogasawara S; Kawahara A; Nishida N; Sanada S; Moriya F; Kuwano M; Nakashima O; Yano H Oncol Rep; 2008 Dec; 20(6):1329-35. PubMed ID: 19020710 [TBL] [Abstract][Full Text] [Related]
3. N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expression. Hosoi F; Izumi H; Kawahara A; Murakami Y; Kinoshita H; Kage M; Nishio K; Kohno K; Kuwano M; Ono M Cancer Res; 2009 Jun; 69(12):4983-91. PubMed ID: 19491262 [TBL] [Abstract][Full Text] [Related]
4. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198 [TBL] [Abstract][Full Text] [Related]
5. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology. Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of E-cadherin and ezrin immunohistochemical expression in prostate cancer. MusiaĆ J; Sporny S; Nowicki A Pol J Pathol; 2007; 58(4):235-43. PubMed ID: 18459457 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients. Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286 [TBL] [Abstract][Full Text] [Related]
8. Cap43/NDRG1/Drg-1 is a molecular target for angiogenesis and a prognostic indicator in cervical adenocarcinoma. Nishio S; Ushijima K; Tsuda N; Takemoto S; Kawano K; Yamaguchi T; Nishida N; Kakuma T; Tsuda H; Kasamatsu T; Sasajima Y; Kage M; Kuwano M; Kamura T Cancer Lett; 2008 Jun; 264(1):36-43. PubMed ID: 18281151 [TBL] [Abstract][Full Text] [Related]
9. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Umbas R; Isaacs WB; Bringuier PP; Schaafsma HE; Karthaus HF; Oosterhof GO; Debruyne FM; Schalken JA Cancer Res; 1994 Jul; 54(14):3929-33. PubMed ID: 7518346 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer. Mell LK; Meyer JJ; Tretiakova M; Khramtsov A; Gong C; Yamada SD; Montag AG; Mundt AJ Clin Cancer Res; 2004 Aug; 10(16):5546-53. PubMed ID: 15328195 [TBL] [Abstract][Full Text] [Related]
11. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells. Fotovati A; Fujii T; Yamaguchi M; Kage M; Shirouzu K; Oie S; Basaki Y; Ono M; Yamana H; Kuwano M Clin Cancer Res; 2006 May; 12(10):3010-8. PubMed ID: 16707596 [TBL] [Abstract][Full Text] [Related]
12. [Correlation and significance of E-cadherin and N-cadherin expression in prostate cancer]. Huang X; Zhou LQ; Ai JK; Lu YQ; Bai Y; Zeng L; Zhang ZW; Guo YL Ai Zheng; 2002 Nov; 21(11):1208-11. PubMed ID: 12526217 [TBL] [Abstract][Full Text] [Related]
13. Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion. Strzelczyk B; Szulc A; Rzepko R; Kitowska A; Skokowski J; Szutowicz A; Pawelczyk T Ann Surg Oncol; 2009 May; 16(5):1287-94. PubMed ID: 19259744 [TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of E-cadherin and beta-catenin in human prostate cancer. Jaggi M; Johansson SL; Baker JJ; Smith LM; Galich A; Balaji KC Urol Oncol; 2005; 23(6):402-6. PubMed ID: 16301117 [TBL] [Abstract][Full Text] [Related]
15. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer. Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237 [TBL] [Abstract][Full Text] [Related]
16. Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer. Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Kosma VM Br J Cancer; 1999 May; 80(3-4):477-82. PubMed ID: 10408856 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of Cap43 is associated with malignant status of esophageal cancer. Sohda M; Mochida Y; Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Fukai Y; Masuda N; Ono M; Kuwano M; Kuwano H Anticancer Res; 2009 Apr; 29(4):965-70. PubMed ID: 19414333 [TBL] [Abstract][Full Text] [Related]
18. Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. Richmond PJ; Karayiannakis AJ; Nagafuchi A; Kaisary AV; Pignatelli M Cancer Res; 1997 Aug; 57(15):3189-93. PubMed ID: 9242448 [TBL] [Abstract][Full Text] [Related]
19. Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells. Murakami Y; Hosoi F; Izumi H; Maruyama Y; Ureshino H; Watari K; Kohno K; Kuwano M; Ono M Biochem Biophys Res Commun; 2010 May; 396(2):376-81. PubMed ID: 20416281 [TBL] [Abstract][Full Text] [Related]
20. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Umbas R; Schalken JA; Aalders TW; Carter BS; Karthaus HF; Schaafsma HE; Debruyne FM; Isaacs WB Cancer Res; 1992 Sep; 52(18):5104-9. PubMed ID: 1516067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]